What health professionals do with the person in front of them who's at high risk already, who has cardiovascular disease, or whose overweight is contributing to their risk. It's timely, because we've got GLP-1 therapies available for the first time, which not only help people control their weight, but also have consequences in terms of reducing cardiovascular events and improving outcomes. Australia leading the world in GLP-1 guidance Prof
Most participants seeing 8-10% reduction by week 12
Muscle preservation, gut health, and hydration as new purchase drivers People are now paying more attention to what their food can do for their health
In a document circulated to employees, Cigna suggested those currently using the medications can choose to pay for the drugs with cash through manufacturer sites or TrumpRx
Collective Impact: The participant group achieved a cumulative weight loss of 2,732 kg
Retatrutide (LY3437943 40 mg) GLP-1 + GIP + Eli Lilly